GABAA-rho receptor

From WikiMD's Food, Medicine & Wellness Encyclopedia

GABAA-rho receptor, also known as the GABAA-ρ receptor or GABAC receptor, is a type of GABA receptor that is distinct from the more common GABAA receptor. It is a ligand-gated ion channel that is primarily permeable to chloride ions, which when activated, leads to an inhibitory effect on neurotransmission. This receptor subtype is predominantly found in the retina, but it is also present in other parts of the central nervous system.

Structure[edit | edit source]

The GABAA-rho receptor is a pentamer composed of rho subunits, which can form homopentamers or heteropentamers with other rho subunits. Unlike the GABAA receptors, which can be composed of a variety of different subunits (α, β, γ, δ, ε, θ, π, and σ), the GABAA-rho receptor is made up exclusively of rho (ρ) subunits, of which there are three types: ρ1, ρ2, and ρ3. The composition of these subunits affects the receptor's pharmacological properties.

Function[edit | edit source]

The primary role of the GABAA-rho receptor is to mediate inhibitory neurotransmission. When GABA binds to the receptor, it causes the channel to open and chloride ions to flow into the neuron. This influx of chloride ions makes the neuron more negative inside, a process known as hyperpolarization, making it less likely to fire an action potential. This mechanism is crucial for controlling the excitability of neurons and plays a significant role in the processing of visual signals in the retina.

Pharmacology[edit | edit source]

GABAA-rho receptors have a distinct pharmacological profile compared to GABAA receptors. They are insensitive to classical GABAA receptor modulators such as benzodiazepines, barbiturates, and steroids. However, they are selectively modulated by certain compounds, including picrotoxin and ethanol, which can influence their function. Understanding the pharmacology of these receptors is important for developing drugs that can target specific receptor subtypes without affecting others, potentially reducing side effects.

Clinical Significance[edit | edit source]

Alterations in GABAA-rho receptor function have been implicated in various neurological disorders, including epilepsy, anxiety disorders, and schizophrenia. Research into these receptors may lead to new therapeutic targets for these conditions. Additionally, due to their role in the retina, GABAA-rho receptors are also being studied in the context of retinal diseases and visual impairments.

Research Directions[edit | edit source]

Current research on GABAA-rho receptors focuses on understanding their precise role in the central nervous system and the retina, their pharmacological properties, and how they can be targeted for therapeutic purposes. There is also interest in exploring how these receptors interact with other types of GABA receptors and their involvement in the overall regulation of inhibitory neurotransmission.



Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD